Altogether, these studies confirm the hypothesis that cancer cells modulate the TRAP1 expression to remodel the balance between the glycolytic and oxidative metabolism in response to extracellular stimuli, and that this may be relevant for drug resistance and tumor progression. The gene discussed is TRAP1; the disease is cancer.